Comparison of botulinum toxins A and B in the treatment of facial rhytides - 24/08/11
Doi : 10.1016/S0733-8635(03)00040-8
Neil S Sadick, MD ⁎, a 
, Seth L Matarasso, MD b
, Seth L Matarasso, MD b a Department of Dermatology, Weill Medical College, Cornell University, 772 Park Avenue, New York, NY 10021, USA
b Department of Dermatology, University of California School of Medicine, 490 Post Street, Suit 700, San Francisco, CA 94102, USA
*Corresponding author
Plan
 | At the time this manuscript was developed, Dr. Sadick and Dr. Matarasso were not consultants for either Elan Pharmaceuticals or Allergan, Inc. No financial support was received for any studies involving botulinum toxins A or B. |
© 2004
Elsevier Inc. Tous droits réservés.
Vol 22 - N° 2
P. 221-226 - avril 2004 Retour au numéro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?